Tirtha Chakraborty
43Patents
25h-index
30Co-inventors
81Inventor score
Filing activity: Mar 9, 2013 → Feb 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8999380B2 | Modified polynucleotides for the production of biologics and proteins associated with human disease | Emerging Cross-Sectional Technologies | 177 | Active |
| US9303079B2 | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins | Chemistry; Metallurgy | 174 | Active |
| US9061059B2 | Modified polynucleotides for treating protein deficiency | Emerging Cross-Sectional Technologies | 173 | Active |
| US9597380B2 | Terminally modified RNA | Chemistry; Metallurgy | 125 | Active |
| US9107886B2 | Modified polynucleotides encoding basic helix-loop-helix family member E41 | Chemistry; Metallurgy | 113 | Active |
| US9095552B2 | Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1 | Emerging Cross-Sectional Technologies | 112 | Active |
| US9114113B2 | Modified polynucleotides encoding citeD4 | Emerging Cross-Sectional Technologies | 112 | Active |
| US9089604B2 | Modified polynucleotides for treating galactosylceramidase protein deficiency | Emerging Cross-Sectional Technologies | 108 | Active |
| US9220755B2 | Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders | Chemistry; Metallurgy | 101 | Active |
| US9254311B2 | Modified polynucleotides for the production of proteins | Chemistry; Metallurgy | 100 | Active |
| US9221891B2 | In vivo production of proteins | Chemistry; Metallurgy | 98 | Active |
| US9675668B2 | Modified polynucleotides encoding hepatitis A virus cellular receptor 2 | Emerging Cross-Sectional Technologies | 96 | Active |
| US9233141B2 | Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders | Emerging Cross-Sectional Technologies | 93 | Active |
| US9192651B2 | Modified polynucleotides for the production of secreted proteins | Emerging Cross-Sectional Technologies | 91 | Active |
| US9220792B2 | Modified polynucleotides encoding aquaporin-5 | Emerging Cross-Sectional Technologies | 89 | Active |
| US9301993B2 | Modified polynucleotides encoding apoptosis inducing factor 1 | Emerging Cross-Sectional Technologies | 81 | Active |
| US9283287B2 | Modified polynucleotides for the production of nuclear proteins | Chemistry; Metallurgy | 76 | Active |
| US9572896B2 | In vivo production of proteins | Chemistry; Metallurgy | 65 | Active |
| US9587003B2 | Modified polynucleotides for the production of oncology-related proteins and peptides | Chemistry; Metallurgy | 59 | Active |
| US9572897B2 | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins | Chemistry; Metallurgy | 52 | Active |
| US9504734B2 | Modified polynucleotides for the production of nuclear proteins | Chemistry; Metallurgy | 50 | Active |
| US10772975B2 | Modified Polynucleotides for the production of biologics and proteins associated with human disease | Emerging Cross-Sectional Technologies | 34 | Active |
| US11027025B2 | Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of use | Chemistry; Metallurgy | 32 | Active |
| US9149506B2 | Modified polynucleotides encoding septin-4 | Emerging Cross-Sectional Technologies | 30 | Active |
| US9050297B2 | Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator | Emerging Cross-Sectional Technologies | 29 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.